Mitsumi Terada
Overview
Explore the profile of Mitsumi Terada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mizusawa J, Ogawa G, Terada M, Ishiki H, Kikawa Y, Kiyota N
Cureus
. 2024 Jun;
16(5):e60804.
PMID: 38910767
The Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) initiative was established in 2016 to assess the quality and standardization of patient-reported outcomes (PRO)...
2.
Makuuchi R, Terashima M, Terada M, Mizusawa J, Kita R, Tokunaga M, et al.
BMC Cancer
. 2023 Oct;
23(1):987.
PMID: 37845660
Background: Laparoscopic gastrectomy (LG) is considered a standard treatment for clinical stage I gastric cancer. Nevertheless, LG has some drawbacks, such as motion restriction and difficulties in spatial perception. Robot-assisted...
3.
Terada M, Nakamura K, Matsuda T, Okuma H, Sudo K, Yusof A, et al.
Jpn J Clin Oncol
. 2023 Apr;
53(7):619-628.
PMID: 37099440
This report summarizes the presentations and discussions in the first Asian Clinical Trials Network for Cancers (ATLAS) international symposium that was held on 24 April 2022, in Bangkok, Thailand, and...
4.
Ishiki H, Kikawa Y, Terada M, Mizusawa J, Honda M, Iwatani T, et al.
Jpn J Clin Oncol
. 2023 Jan;
53(3):195-202.
PMID: 36702740
Assessments of patient-reported outcomes and health-related quality of life in cancer clinical trials have been increasingly emphasized recently because patient and public involvement in cancer treatment development has been promoted...
5.
Rowsell A, Sodergren S, Vassiliou V, Darlington A, Guren M, Alkhaffaf B, et al.
Gastric Cancer
. 2022 Oct;
26(1):167.
PMID: 36269499
No abstract available.
6.
Rowsell A, Sodergren S, Vassiliou V, Darlington A, Guren M, Alkhaffaf B, et al.
Gastric Cancer
. 2022 Jun;
25(4):665-677.
PMID: 35689705
The treatment landscape for gastric cancer (GC) is constantly evolving with therapies affecting all aspects of health-related quality of life (HRQoL) which need careful monitoring. While there are HRQoL measures...
7.
Terada M, Nakamura K, Martinelli F, Pe M, Mizusawa J, Eba J, et al.
Jpn J Clin Oncol
. 2020 Aug;
50(11):1333-1341.
PMID: 32783053
This report summarizes the presentations and discussion in the first Japan Clinical Oncology Group-European Organisation for Research and Treatment of Cancer Quality of Life/Patient-Reported Outcome workshop funded by the National...
8.
de Rojas T, Neven A, Terada M, Garcia-Abos M, Moreno L, Gaspar N, et al.
JNCI Cancer Spectr
. 2020 Apr;
3(4):pkz057.
PMID: 32337483
Background: The 18-year-old age limit for inclusion in clinical trials constitutes a hurdle for adolescents and young adults (AYAs) with cancer. We analyzed the impact of this age barrier on...
9.
Vinches M, Neven A, Fenwarth L, Terada M, Rossi G, Kelly S, et al.
BMJ Support Palliat Care
. 2020 Mar;
10(2):249-258.
PMID: 32209567
Objective: This metaresearch of the clinicaltrials.gov database aims to evaluate how clinical research on palliative care is conducted within the setting of advanced cancer. Methods: Clinicaltrials.gov was searched to identify...
10.
Wagner A, Lordick F, Grabsch H, Terashima M, Terada M, Yoshikawa T, et al.
Eur J Cancer
. 2019 Nov;
124:67-76.
PMID: 31759294
The aim of this manuscript is to discuss the viewpoint of the European Organisation for Research and Treatment of Cancer (EORTC) Gastric Cancer Taskforce and Japan Clinical Oncology Group (JCOG)...